We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RNAi Tools for Study of SARS Virus

By Biotechdaily staff writers
Posted on 12 Jun 2003
A library of short interfering RNA (siRNA) duplexes targeted against multiple regions of the coronavirus, believed to cause severe acute respiratory syndrome (SARS), is designed to help researchers study the lifecycle and pathogenicity of the virus and facilitate the development of therapeutics and vaccines. More...
Called SARS siArray Gene Set, the library is the product of Dharmacon, Inc. (Lafayette, CO, USA; www.dharmacon.com). The developers used the Toronto (Canada) SARS sequence, identifying 25 regions within the viral genome that carry the genetic information for key viral proteins that will be individually targeted with siRNA duplexes, including the 14 predicted open reading frames (ORFs).

"The SARS siArray Gene Set guarantees potent gene silencing and is priced to maximize its availability to a broad range of scientists seeking to unravel the molecular genetics of SARS pathogenesis,” said William S. Marshall, Ph.D., executive vice president of research and production at Dharmacon.

In a related development, Qiagen (Hilden, Germany) is also offering a SARS-Coronavirus siRNA Set, which allows gene silencing studies of coronavirus replication and cytopathology in mammalian cell culture. The 40 siRNA duplexes in the set were designed to target each of the 10 identified open reading frames (ORFs) of the SARS coronavirus. Regions of the ORFs were chosen that avoided known areas of sequence divergence in the genome sequences reported in GenBank. A comprehensive homology analysis was performed to ensure that there was no cross homology to known human genes, maximizing the gene-silencing potential.





Related Links:
Dharmacon
Qiagen

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automatic CLIA Analyzer
Shine i6000
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.